Progression of Hematopoietic Diseases in Shanghai, China

Completed

• Conditions: Hematologic Diseases

• Registration Number: NCT00365014
• Lead Sponsor: University of Colorado, Denver

Brief Summary

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility.

Detailed Description

The purpose of this study is to identify and characterize blood diseases presenting at Shanghai hospitals and to compare them with respect to clinical presentation, phenotype, molecular characteristics, benzene or other exposures and genetic susceptibility. The format for these studies is a set of clinical series superimposed on a case-control design that enables integration of detailed clinical and molecular characterizations of disease pathogenesis together with an evaluation of potential confounding and interacting factors within a structured statistical analysis of benzene exposure.

Study Timeline

• Study Start: 2003-08
• Study First Submitted: 2006-08-14
• Study First Submitted QC: 2006-08-14
• Study First Posted: 2006-08-16
• Primary Completion: 2009-12
• Study Completion: 2009-12
• Status Verified: 2013-07
• Last Update Submitted: 2013-07-19
• Last Update Posted: 2013-07-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 10757

Inclusion Criteria

Men and women 18 years or older Diagnosis of hematologic abnormality

Read More

Exclusion Criteria

Children Non hematologic diseases

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
blood diseases presenting at Shanghai hospitals	hospital stay	characterization of people with blood diseases presenting at Shanghai hospitals

Trial Locations

Locations (1)

Joint Sino-US Clinical and Molecular Laboratory (JCML); 🇨🇳 Shanghai, China